Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Takumi Kawaguchi, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):177-180. Published online August 26, 2021

DOI: https://doi.org/10.3350/cmh.2021.0246

View: 2730 Download: 122 Citation: 1

Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki

Clin Mol Hepatol. 2018;24(1):61-76. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0030

View: 7703 Download: 154 Citations: 22

Michael G. Tovey

Clin Mol Hepatol. 2002;8(2):125-131. Published online January 1, 1970

View: 3697 Download: 26

Jong Myung Lee , Young Oh Kweon , Nung Soo Kim

Clin Mol Hepatol. 1997;3(2):170-178. Published online January 1, 1970

View: 8702 Download: 11

1 |

Viewed By 4639	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3551	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2592	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2266	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2209	Recent updates on the management of autoimmune hepatitis

Cited By 89	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 34	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search